Hayfever Relief

Hayfever Relief is an ocular drug that contains the mast‑cell stabilizer sodium cromoglicate as its active ingredient. It is distributed in the European Union and is presented in a topical eye‑drop form, although the specific strength is not disclosed. The product is classified as an antiallergic agent and works by preventing the release of histamine and other inflammatory mediators from mast cells in the eye.

Hayfever Relief is indicated for the management of ocular allergic conditions that are associated with hay fever and seasonal allergens.

- Allergic conjunctivitis caused by seasonal pollen exposure. - Ocular symptoms of hay fever such as itching, redness, and tearing. - Mild to moderate allergic eye irritation due to dust or animal dander. - Prevention of mast‑cell degranulation in the conjunctiva to reduce inflammatory response. - Adjunctive therapy for patients using antihistamine eye drops who need additional mast‑cell stabilization. - Use as part of a comprehensive allergy management plan to reduce reliance on oral antihistamines.

The safety profile of Hayfever Relief reflects its local ocular administration, with most reported events being mild and transient.

Common: - Temporary eye irritation or burning sensation after instillation. - Mild blurred vision that resolves within minutes. - Slight eye redness or watery discharge. - Minor headache unrelated to systemic absorption. - Temporary sensation of dryness after use. - Transient mild conjunctival swelling that resolves without treatment.

Serious: - Persistent eye pain or worsening redness. - Signs of allergic reaction such as swelling of the eyelids. - Development of corneal ulceration. - Severe visual disturbance requiring medical attention. - Development of allergic contact dermatitis around the eye. - Sudden loss of vision or sudden increase in intra‑ocular pressure.

Before using Hayfever Relief, certain precautions should be considered to ensure safe and effective use.

- Do not use if you have a known hypersensitivity to sodium cromoglicate or any excipients. - Avoid contact lens wear for at least 15 minutes after each dose. - Consult an eye‑care professional if symptoms persist beyond a week. - Use with caution in patients with pre‑existing ocular infections or inflammation. - Pregnant or breastfeeding individuals should seek medical advice before initiating therapy. - Keep the container tightly closed and store at room temperature away from direct sunlight. - Do not share the eye‑drop bottle with other individuals to avoid cross‑contamination.

Hayfever Relief may interact with other ophthalmic products, and certain combinations should be avoided or monitored.

Avoid: - Concurrent use of other mast‑cell stabilizer eye drops without professional guidance. - Simultaneous administration of preservative‑containing eye solutions that may increase irritation. - Using eye drops containing high concentrations of preservatives concurrently, which may increase ocular irritation.

Use with caution: - Combining with topical corticosteroid eye drops; monitor for additive effects on intra‑ocular pressure. - Use alongside antihistamine eye drops; assess for overlapping ocular side effects. - Co‑administration with systemic antihistamines; observe for any unexpected systemic reactions. - Co‑administration with systemic immunosuppressants; monitor for any changes in ocular healing. - Combining with other ocular lubricants; evaluate for cumulative preservative load.